Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial of Camptothecin-20-O-Propionate Hydrate (CZ48)

NCT02575638 is registered in ClinicalTrials.gov with Cao Pharmaceuticals Inc. as lead sponsor.

NCT NCT02575638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02575638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial of Camptothecin-20-O-Propionate Hydrate (CZ48)
Lead sponsor
Cao Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2008
Completion date
February 1, 2020
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant lymphoma of extranodal and/or solid organ site, solid tumor